Skip to main navigation Skip to search Skip to main content

Correction: A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion

  • Dhabya Majid
  • , Zhe Wang
  • , Amanda M. Schalk
  • , Bin Yuan
  • , Qi Zhang Tatarata
  • , Jessica L. Root
  • , Araceli Isabella Garza
  • , Mhd Yousuf Yassouf
  • , Basant T. Gamal
  • , Sammy Feri-Borgogno
  • , Annie Hoai Nguyen
  • , Marina Konopleva
  • , Evelien Peeters
  • , Ying Su
  • , Patrick K. Reville
  • , Farhad Ravandi-Kashani
  • , Arnon Lavie
  • , Hussein A. Abbas

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article number1824040
JournalFrontiers in Oncology
Volume16
DOIs
StatePublished - Apr 23 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AML
  • AML with deletion 7
  • acute myeliod leukemia
  • asparaginase
  • combination treatment
  • leukemia
  • venetoclax

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this